MANKIND PHARMA
|
MANKIND PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,333 Cr | ₹2,525 Cr | ₹2,399 Cr | ₹1,671 Cr | ₹1,975 Cr |
| Adjustment | ₹1,277 Cr | ₹602 Cr | ₹212 Cr | ₹298 Cr | ₹31 Cr |
| Changes In working Capital | ₹105 Cr | ₹-146 Cr | ₹-18 Cr | ₹167 Cr | ₹-586 Cr |
| Cash Flow after changes in Working Capital | ₹3,714 Cr | ₹2,980 Cr | ₹2,594 Cr | ₹2,136 Cr | ₹1,419 Cr |
| Cash Flow from Operating Activities | ₹3,121 Cr | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr |
| Cash Flow from Investing Activities | ₹-196 Cr | ₹-12,683 Cr | ₹-2,082 Cr | ₹-1,054 Cr | ₹-1,369 Cr |
| Cash Flow from Financing Activities | ₹-2,953 Cr | ₹10,233 Cr | ₹5.27 Cr | ₹-740 Cr | ₹605 Cr |
| Net Cash Inflow / Outflow | ₹-28 Cr | ₹-37 Cr | ₹76 Cr | ₹19 Cr | ₹155 Cr |
| Opening Cash & Cash Equivalents | ₹404 Cr | ₹382 Cr | ₹305 Cr | ₹283 Cr | ₹127 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | ₹-9.40 Cr | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | ₹67 Cr | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹16 Cr | ₹1.31 Cr | ₹1.17 Cr | ₹2.32 Cr | ₹0.48 Cr |
| Closing Cash & Cash Equivalent | ₹392 Cr | ₹404 Cr | ₹382 Cr | ₹305 Cr | ₹283 Cr |
Compare Cashflow Statement of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,276.3 Cr | -0.6% | 6.5% | 7.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.6% |
6.5% |
7.1% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses